NCT01709721View on ClinicalTrials.gov

Safety and Efficacy Study of Hydromorphone Hydrochloride by Intrathecal Administration

PHASE3CompletedINTERVENTIONAL
Enrollment

153

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions
Management of Chronic Pain
Interventions
DRUG

Hydromorphone Hydrochloride

Opioid for chronic pain

DEVICE

Programmable Implantable pump

Programmable Implantable pump delivering intrathecal hydromorphone

Trial Locations (1)

27103

The Center for Clinical Research, Winston-Salem

All Listed Sponsors
lead

Piramal Critical Care, Ltd.

INDUSTRY

NCT01709721 - Safety and Efficacy Study of Hydromorphone Hydrochloride by Intrathecal Administration | Biotech Hunter | Biotech Hunter